Position in VKTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$17,587,837
-$17,335,173 QoQ
Shares Held
540,499
-45.6% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$7,884
PutShares
300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,837,016 across 415 Biotechnology names. VKTX ranks #41 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in VKTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,587,837 | 540,499 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $34,923,010 | 992,695 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $7,884 | 300 | Put | Defined | 2025-11-13 | |
| 2025-09-30 | $4,107,800 | 156,309 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,452,609 | 168,023 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,188,891 | 504,716 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,879,248 | 46,701 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,489,736 | 86,712 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,614,240 | 256,824 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,429,948 | 78,414 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $4,511,529 | 242,425 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,186,740 | 378,206 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,298,201 | 573,609 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $4,025,870 | 241,794 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $467,584 | 49,743 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $848 | 312 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $15,322 | 5,302 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,618 | 10,206 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $119,135 | 25,899 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $108,832 | 17,330 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $64,110 | 10,703 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $216,656 | 34,254 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $51,604 | 9,166 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $89,272 | 15,339 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $69,208 | 9,599 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $195,858 | 41,850 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||